Jessner–Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?

L. Sparsa(Hôpitaux Universitaires de Strasbourg), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Christelle Sordet, Emmanuel Chatelus(Laboratoire National de Référence), Naji Afif(Centre Hospitalier de Mulhouse), Joëlle Goetz(Hôpitaux Universitaires de Strasbourg), Dan Lipsker(Hôpitaux Universitaires de Strasbourg)
Rheumatology International
October 12, 2009
10.1007/s00296-009-1169-z
Cited by 16

Related Papers

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
|Blood|1997|346
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207